The Rationale and Design of the Reducing Pathology in Alzheimer’s Disease through Angiotensin TaRgeting (RADAR) Trial

NiftyFit: a Software Package for Multi-parametric Model-Fitting of 4D Magnetic Resonance Imaging Data

(2016) Andrew Melbourne et al.   NEUROINFORMATICS

Factors affecting therapeutic compliance: A review from the patient’s perspective

(2016) Shu-Chuen Li   Therapeutics and Clinical Risk Management

Bayesian Model Selection for Pathological Neuroimaging Data Applied to White Matter Lesion Segmentation

(2015) Carole H. Sudre et al.   IEEE TRANSACTIONS ON MEDICAL IMAGING

Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

(2014) Stephen Salloway et al.   NEW ENGLAND JOURNAL OF MEDICINE

STEPS: Similarity and Truth Estimation for Propagated Segmentations and its application to hippocampal segmentation and brain parcelation

(2013) M. Jorge Cardoso et al.   MEDICAL IMAGE ANALYSIS

Progress in the development of new drugs in Alzheimer’s disease

(2011) Antoine Piau et al.   Journal of Nutrition Health & Aging

Bias in tensor based morphometry Stat-ROI measures may result in unrealistic power estimates

(2011) Wesley K. Thompson et al.   NEUROIMAGE

Accurate measurement of brain changes in longitudinal MRI scans using tensor-based morphometry

(2011) Xue Hua et al.   NEUROIMAGE

Algorithms, atrophy and Alzheimer's disease: Cautionary tales for clinical trials

(2011) Nick C. Fox et al.   NEUROIMAGE

Brain MAPS: An automated, accurate and robust brain extraction technique using a template library

(2011) Kelvin K. Leung et al.   NEUROIMAGE

Association of Plasma Aß Peptides with Blood Pressure in the Elderly

(2011) Jean-Charles Lambert et al.   PLoS One

Longitudinal Changes in White Matter Disease and Cognition in the First Year of the Alzheimer Disease Neuroimaging Initiative

(2010) Owen Carmichael   ARCHIVES OF NEUROLOGY

Placebo-Controlled Trials of Blood Pressure–Lowering Therapies for Primary Prevention of Dementia

(2010) Jan A. Staessen et al.   HYPERTENSION

Higher activity of peripheral blood angiotensin-converting enzyme is associated with later-onset of Alzheimer's disease

(2010) Hiroyasu Akatsu et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies

(2010) Craig Anderson et al.   LANCET NEUROLOGY

The clinical use of structural MRI in Alzheimer disease

(2010) Giovanni B. Frisoni et al.   Nature Reviews Neurology

Reduced sample sizes for atrophy outcomes in Alzheimer's disease trials: baseline adjustment

(2010) J.M. Schott et al.   NEUROBIOLOGY OF AGING

Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer's disease

(2010) Kelvin K. Leung et al.   NEUROIMAGE

Angiotensin II AT1 Receptor Blockade Ameliorates Brain Inflammation

(2010) Julius Benicky et al.   NEUROPSYCHOPHARMACOLOGY

Protective Effects of Intranasal Losartan in the APP/PS1 Transgenic Mouse Model of Alzheimer Disease

(2010) Lusine Danielyan et al.   REJUVENATION RESEARCH

Effect of cilnidipine vs losartan on cerebral blood flow in hypertensive patients with a history of ischemic stroke: a randomized controlled trial

(2009) K.-S. Hong et al.   ACTA NEUROLOGICA SCANDINAVICA

Neprilysin and Insulin-Degrading Enzyme Levels Are Increased in Alzheimer Disease in Relation to Disease Severity

(2009) James Scott Miners et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Robust atrophy rate measurement in Alzheimer's disease using multi-site serial MRI: Tissue-specific intensity normalization and parameter selection

(2009) Kelvin K. Leung et al.   NEUROIMAGE

Angiotensins in Alzheimer's disease – friend or foe?

(2009) Patrick G. Kehoe et al.   TRENDS IN NEUROSCIENCES

The rationale and design of the antihypertensives and vascular, endothelial, and cognitive function (AVEC) trial in elderly hypertensives with early cognitive impairment: Role of the renin angiotensin system inhibition

(2009) Ihab Hajjar et al.   BMC Geriatrics

Telmisartan prevented cognitive decline partly due to PPAR-γ activation

(2008) Masaki Mogi et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

SYMPOSIUM: Clearance of Aβ from the Brain in Alzheimer's Disease: Aβ-Degrading Enzymes in Alzheimer's Disease

(2008) James Scott Miners et al.   BRAIN PATHOLOGY

The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods

(2008) Clifford R. Jack et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Prevention of progression to dementia in the elderly: Rationale and proposal for a health-promoting memory consultation (an IANA task force)

(2008) S. Gillette-Guyonnet et al.   Journal of Nutrition Health & Aging

Linking cerebrovascular defense mechanisms in brain ageing and Alzheimer's disease

(2008) Raj N. Kalaria   NEUROBIOLOGY OF AGING

Systematic review: blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia

(2007) B McGuinness et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy

(2007) J. S. Miners et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY